In Brief Ophira Ginsburg named director of NYU cancer center’s High Risk Program April 14, 2017Vol.43 No.15
ASCO says “right-to-try” laws don’t safeguard patients and fail to address problems in obtaining therapies April 14, 2017Vol.43 No.15By Paul Goldberg
U.S. cancer costs add up to $87.8 billion; Patients pay $4 billion out-of-pocket April 14, 2017Vol.43 No.15
Permanent advisory board needed to combat scientific misconduct, NAS report recommends April 14, 2017Vol.43 No.15By Paul Goldberg
Guest Editorial How not to develop a medical intervention: Learning from the prostate screening debacle April 14, 2017Vol.43 No.15By Otis W. Brawley
Conversation with The Cancer Letter Doug Ulman: MD Anderson trademark lawsuit is a frustrating “distraction from our core mission” April 14, 2017Vol.43 No.15By Matthew Bin Han Ong
“ONE GOAL” VS. ANOTHERMD ANDERSON CLAIMS TRADEMARK INFRINGEMENT BY OHIO STATE’S FUNDRAISER April 14, 2017Vol.43 No.15By Matthew Bin Han Ong
Drugs & Targets FDA approves AstraZeneca’s Tagrisso for EGFR mutation-positive NSCLC March 31, 2017Vol.43 No.13
